Search results
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
United Press International via Yahoo News· 6 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 6 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical...
Medical Xpress· 7 days agoThe trial treated 14 prostate stem cell antigen (PSCA)-positive patients who had metastatic castration resistant prostate cancer (mCRPC), which had spread beyond the prostate and no longer responded ...
Boosting CAR-T cell therapies from under the skin
Medical Xpress· 7 days agoOncological researchers suspect that disappointing treatment results can be the result of several circumstances, including poor quality of the CAR-T < ...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 7 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 5 days agoNew research provides insight into ultra-rare case of secondary cancer in a patient who received CAR...
APAC leaps ahead in adoptive cell therapy space
Pharmaceutical Technology via Yahoo Finance· 1 day agoHe also highlighted that overall, there are 1,023 single country adoptive cell therapy clinical studies being run in the APAC region compared to 476 in...
Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke
MedPage Today· 4 days agoTTHealthWatch is a weekly podcast from Texas Tech. This week's topics include eye training to...
Why Is Mustang Bio (MBIO) Stock Up 347% Today?
InvestorPlace· 1 day agoThe recent news includes favorable results from the company’s Phase 1/2 clinical trial of MB-106. This is a CD20-targeted, autologous CAR T-cell ...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 2 days agoT cell immunotherapies. The agency said it had determined that the risk of T-cell malignancies was...